A61P 13/02
Drugs for disorders of the urinary system: of urine or of the
Official title: of urine or of the urinary tract, e.g. urine acidifiers
A61P13/02 (Drugs for disorders of the urinary system: of urine or of the) appears on 5,246 US grants and 5,800 published applications in this corpus.
Search patents in A61P- Granted patents
- 5,246
- Published applications
- 5,800
- Assignees
- 1,977
- Inventors
- 12,181
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 12 | 0 |
| 1979 | 6 | 0 |
| 1980 | 9 | 0 |
| 1981 | 17 | 0 |
| 1982 | 14 | 0 |
| 1983 | 10 | 0 |
| 1984 | 14 | 0 |
| 1985 | 15 | 0 |
| 1986 | 20 | 0 |
| 1987 | 22 | 0 |
| 1988 | 28 | 0 |
| 1989 | 41 | 0 |
| 1990 | 62 | 0 |
| 1991 | 72 | 0 |
| 1992 | 67 | 0 |
| 1993 | 92 | 0 |
| 1994 | 76 | 0 |
| 1995 | 138 | 0 |
| 1996 | 141 | 0 |
| 1997 | 195 | 0 |
| 1998 | 212 | 0 |
| 1999 | 170 | 0 |
| 2000 | 158 | 0 |
| 2001 | 138 | 35 |
| 2002 | 119 | 152 |
| 2003 | 111 | 224 |
| 2004 | 86 | 288 |
| 2005 | 83 | 290 |
| 2006 | 163 | 308 |
| 2007 | 117 | 290 |
| 2008 | 127 | 355 |
| 2009 | 162 | 376 |
| 2010 | 210 | 444 |
| 2011 | 192 | 320 |
| 2012 | 235 | 340 |
| 2013 | 236 | 265 |
| 2014 | 268 | 302 |
| 2015 | 224 | 268 |
| 2016 | 177 | 237 |
| 2017 | 173 | 242 |
| 2018 | 170 | 210 |
| 2019 | 165 | 199 |
| 2020 | 135 | 164 |
| 2021 | 105 | 113 |
| 2022 | 67 | 103 |
| 2023 | 57 | 79 |
| 2024 | 49 | 81 |
| 2025 | 64 | 71 |
| 2026 | 14 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Selective angiotensin II receptor ligands18 Aug 2026US 12,708,615 B2Vicore Pharma AB
- Acetylcholinesterase inhibitor11 Aug 2026US 12,702,148 B2Taiko Pharmaceutical Co., Ltd.
- BCAT modulation11 Aug 2026US 12,703,697 B2Icagen, Inc.
- Compositions comprising an American cranberry extract and phospholipids7 Jul 2026US 12,673,079 B2Indena S. P. A.
- Microbiome compositions16 Jun 2026US 12,653,846 B2B.Y.M. Technologies
- Substituted pyrimidinone and azapyrimidinone compounds, compositions, and uses thereof1 Oct 2026US 2026/0297118 A1
- Compositions and Methods for Increasing Urination24 Sep 2026US 2026/0284131 A1YUJIAN International Biotechnology, Inc.
- Method of treating lower tract urothelial cancer27 Aug 2026US 2026/0248717 A1TARIS Biomedical LLC
- Urination disorder-alleviating agent27 Aug 2026US 2026/0248769 A1Zeria Pharmaceutical Co., Ltd.
- Methods for treating igg4-related diseases27 Aug 2026US 2026/0250393 A1Xencor, Inc.
Most cited
By later US patents
- Zinc finger protein derivatives and methods therefor323US 6,140,466 AThe Scripps Research Institute · 2000
- Zinc finger protein derivatives and methods therefor315US 6,242,568 B1The Scripps Research Institute · 2001
- Pharmaceutical compositions containing an omega-3 fatty acid oil306US 6,284,268 B1Cyclosporine Therapeutics Limited · 2001
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Controlled release matrix for pharmaceuticals245US 5,811,126 AEuro-Celtique S. A. · 1998